Controversies in locoregional management of breast cancer with low volume pN0(i+) and pN1mi nodal disease

References

• Hotorbagyi GN, Connolly JL, D’Orsi CJ, et al. Breast. In Amin MB, Edge SB, Greene FL, et al, editors. AJCC Cancer Staging Manual. 8th ed. New York: Springer. 2017. p. 589-628.
   Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentienel node metastasis. JAMA. 2011;305:569–575.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Ballman KV, Mccall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis. The ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918–926.
   PubMed Web of Science ®Google Scholar
• Donker M, Van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–1310.
   PubMed Web of Science ®Google Scholar
• Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23 – 01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297–305.
   PubMed Web of Science ®Google Scholar
• Solá M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol. 2013;20:120–127.
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Anderson BO, Abraham J, et al. National comprehensive cancer network guidelines version 1. 2019. Breast Cancer. 2019.
   Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR,B, et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2019;23(30):7703–7720.
   Google Scholar
• Belkacemi Y, Allab-Pan Q, Bigorie V, et al. The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I–II and the sentinel node area. Ann Oncol. 2013;24:2023–2028.
   PubMed Web of Science ®Google Scholar
• Naidoo K, Pinder SE. Micro- and macro-metastasis in the axillary lymph node: a review. Surgeon. 2017;15(2):76–82.
   PubMed Web of Science ®Google Scholar
• Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer : protocol recommendations and rationale. Mod Pathol. 2010;23(S2): S26–32. Nature Publishing Group.
   PubMedGoogle Scholar
• Tallet A, Lambaudie E, Cohen M, et al. Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy. World J Clin Oncol. 2016;7(2):243–252.
   PubMed Web of Science ®Google Scholar
• Dutta SW, Volaric A, Morgan JT, et al. Pathologic evaluation and prognostic implications of nodal icrometastases in breast cancer. Semin Radiat Oncol. 2019;29:102–110.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hawes D, Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011; 306:385-393.
   Google Scholar
• Weaver DL, Ashikaga T, Krag DN, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 2011;364:412–421.
   PubMed Web of Science ®Google Scholar
• de Boer M, Van Deurzen CHM, Borm GF, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. New Engl J Med. 2009;361(7):653–663.
   PubMed Web of Science ®Google Scholar
• Leidenius MH, Vironen JH, Heikkila PS, et al. Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol. 2010;17:254–262.
   PubMed Web of Science ®Google Scholar
• Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg. 2008;206:261–268.
   PubMed Web of Science ®Google Scholar
• Andersson Y, Bergkvist L, Frisell J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat. 2018;171:359–369.
   PubMed Web of Science ®Google Scholar
• Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009;27:4679–4684.
   PubMed Web of Science ®Google Scholar
• Park D, Kåresen R, Naume B, et al. The prognostic impact of occult nodal metastasis in early breast carcinoma. Breast Cancer Res Treat. 2009;118:57–66.
   PubMed Web of Science ®Google Scholar
• Reed J, Rosman M, Verbanac KM, et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina university/Anne Arundel medical center sentinel node multicenter study. J Am Coll Surg. 2009;208:333–340.
   PubMed Web of Science ®Google Scholar
• Pugliese MS, Beatty JD, Tickman RJ, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol. 2009;16:113–120.
   PubMed Web of Science ®Google Scholar
• Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC, et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat. 2011;127:195–203.
   PubMed Web of Science ®Google Scholar
• Keruakous AR, Sadek BT, Shenouda MN, et al. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy. Breast Cancer Res Treat. 2014;146:365–370.
   PubMed Web of Science ®Google Scholar
• van der Heiden-van der Loo M, Schaapveld M, VKY H, et al. Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes. Ann Oncol. 2013;24:2794–2801.
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Sabatier R, Reyal F, et al. Axillary lymph node micrometastases decrease triple-negative early breast cancer survival. Br J Cancer. 2016;115:1024–1031.
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Classe J-M, Garbay J-R, et al. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study. Breast. 2014;23:561–566.
   PubMed Web of Science ®Google Scholar
• Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol. 2014;32:3600–3608.
   PubMed Web of Science ®Google Scholar
• Whelan TJ, Olivotto IA, IParulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. New Engl J Med. 2015;373:307–316.
   PubMed Web of Science ®Google Scholar
• Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–327.
   PubMed Web of Science ®Google Scholar
• Karam I, Lesperance M, Berrang T, et al. pN0(i+) breast cancer: treatment patterns, locoregional recurrence, and survival outcomes. Int J Radiat Oncol Biol Phys. 2013;87:731–737.
   PubMed Web of Science ®Google Scholar
• Setton J, Cody H, Tan L, et al. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection. Cancer. 2012;118:1994–2003.
   PubMed Web of Science ®Google Scholar
• Pepels MJ, de Boer M, Bult P, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg. 2012;255:116–121.
   PubMed Web of Science ®Google Scholar
• EBCTCG. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–2135.
   PubMed Web of Science ®Google Scholar
• Forissier V, Tallet A, Cohen M, et al. Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort. Eur J Cancer. 2017;87:47–57.
   PubMed Web of Science ®Google Scholar
• Wu PS, Tam M, Shaikh F, et al. Post-mastectomy radiation therapy in breast cancer patients with nodal micrometastases. Ann Surg Oncol. 2018;25:2620–2631.
   PubMed Web of Science ®Google Scholar
• Mamtani A, Patil S, Stempel M, et al. Axillary micrometastases and isolated tumor cells are not an indication for post-mastectomy radiotherapy in stage 1 and 2 breast cancer. Ann Surg Oncol. 2017;24(8):2182–2188.
   PubMed Web of Science ®Google Scholar
• Fitzsullivan E, Bassett RL, Kuerer HM, et al. Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy. Ann Surg Oncol. 2017;24:652–659.
   PubMed Web of Science ®Google Scholar